Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 5/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16314131 | 0.90 | POLB (0.46) | POLBMAPTKDM4EGAAACHE | |
| SCHEMBL15025823 | 0.90 | POLB (0.44) | POLBMAPTKDM4EGAAACHE | |
| SCHEMBL9913062 | 0.88 | POLB (0.46) | POLBMAPTKDM4EGAAACHE | |
| SCHEMBL13526113 | 0.86 | GAA (0.60) | POLBMAPTKDM4EGAAHTT | |
| SCHEMBL15784487 | 0.84 | POLB (0.44) | POLBMAPTKDM4EGAAACHE | |
| SCHEMBL29447739 | 0.84 | POLB (0.41) | POLBMAPTKDM4EGAAACHE | |
| SCHEMBL12544709 | 0.84 | POLB (0.41) | POLBMAPTKDM4EGAAACHE | |
| SCHEMBL13231732 | 0.84 | POLB (0.44) | POLBMAPTKDM4EGAAACHE | |
| SCHEMBL13314099 | 0.81 | BCHE (0.38) | POLBMAPTKDM4EGAAACHE | |
| SCHEMBL26578824 | 0.81 | POLB (0.47) | POLBMAPTKDM4EGAAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101884122-B | Use of diphenylamino-bis (phenoxy) triazines and bis (diphenylamino) phenoxytriazine compounds | BASF SE | 2012-06-06 | — | — | CN | disclosed |
| CN-101884122-A | Use of diphenylamino-bis (phenoxy) triazines and bis (diphenylamino) phenoxytriazine compounds | BASF SE | 2010-11-10 | — | — | CN | disclosed |
| US-20100258790-A1 | USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS | BASF SE (DE) | 2010-10-14 | — | — | US | disclosed |
| US-20100258790-A1 | USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS | BASF SE (DE) | 2010-10-14 | — | — | US | disclosed |
| US-20100258790-A1 | USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS | BASF SE (DE) | 2010-10-14 | — | — | US | disclosed |
| EP-2206175-A1 | USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS | BASF SE (DE) | 2010-07-14 | — | — | EP | disclosed |
| WO-2009053346-A1 | USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS | BASF SE (DE) | 2009-04-30 | — | — | WO | disclosed |
| WO-2009053346-A1 | USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS | BASF SE (DE) | 2009-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100258790-A1 | USE OF DIPHENYLAMINO-BIS(PHENOXY)- AND BIS(DIPHENYLAMINO)-PHENOXYTRIAZINE COMPOUNDS | TRPC6, KCNB1, CACNA1I | POLB 1544/4885MAPT 263/4885KDM4E 2135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.